Oral estradiol supplementation modified the dual GHRP-2/GHRH stimulation of GH in postmenopausal women by selectively enhancing GHRP-2's hypothalamic component while reducing somatostatin's inhibitory effect.
Pathway-specificEstrogen enhanced GHRP-2's hypothalamic action specifically while reducing somatostatin — not a blunt effect but surgical precision on specific GH regulatory pathways
What the researchers found
Oral E2 selectively enhanced the GHRP-2 hypothalamic signaling component during combined GHRP-2/GHRH stimulation while reducing somatostatin restraint in postmenopausal women, revealing pathway-specific estrogen modulation of dual-peptide GH stimulation.
Why it matters
This precision understanding of estrogen's effects on each GH-regulatory pathway enables optimized combination therapy — using estrogen to enhance GHRP-2 effectiveness while managing GHRH response.
How the study worked
Clinical trial in postmenopausal women with combined continuous GHRP-2 + GHRH IV infusion. Oral E2 versus placebo. 10-minute blood sampling for GH deconvolution analysis to dissect hypothalamic vs pituitary components.
What this study cannot tell us
Small sample. Oral E2 (first-pass liver effects). Intensive protocol limits clinical translatability. Short-term E2 effects may differ from chronic use.
How to read the evidence
Moderate evidence from an intensive clinical study with pathway-dissecting methodology in the relevant clinical population.
When this study was published
Published in 2002. These findings inform ongoing optimization of GH secretagogue therapy in women.
The bigger picture
Precision endocrinology means understanding how one hormone modifies another's effects at the pathway level. This granular understanding enables truly optimized hormone combination therapy.
Questions still open
- Should postmenopausal women on E2 receive different GHRP-2 doses?
- Does transdermal E2 produce the same pathway-specific modulation?
- Can these findings guide personalized menopause hormone therapy?
Common questions
Does menopause affect how GH peptides work?
Should women on estrogen adjust their GH peptide doses?
Read the original research
Impact of estradiol supplementation on dual peptidyl drive of GH secretion in postmenopausal women.
The Journal of clinical endocrinology and metabolism, 87(2), 859-66
Citation
Veldhuis, J D; Evans, W S; Bowers, C Y. (2002). Impact of estradiol supplementation on dual peptidyl drive of GH secretion in postmenopausal women.. The Journal of clinical endocrinology and metabolism, 87(2), 859-66.